E-consult program for immune-related toxicities reduces costs, increases patient access

An electronic consult program for patients who developed endocrine immune-related adverse events has considerably reduced health care utilization.
“Side effects have existed for as long as cancer therapies have existed,” Afreen Shariff, MD, MBBS, director of the Duke Endo Oncology program and associate director of the cancer therapy toxicity program within Center for Cancer Immunotherapy at Duke Cancer Institute, told Healio.
“With the increased use of targeted therapies and immunotherapy, however, we’ve started seeing a different flavor of side effects that required

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart